HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Business News: BioGaia Acquires US Distributor, Spain's Rubió Enters VMS Market, Sidefarma Gets PE Backing

Executive Summary

Round-up of European consumer health news: Probiotics specialist BioGaia plots US expansion with acquisition of distribution partner; Spain's Rubió enters the dietary supplements space with Fisiopharma; and Portugal's Sidefarma receives investment from private-equity firm Atena.

You may also be interested in...



EU Business News: PharmaSGP Makes Record Start, BioGaia Heads To Canada, Ardian Takes Nutripure Stake

Round-up of European consumer health business news: Germany's PharmaSGP breaks sales record in Q1 as acquired brands grow; probiotics player BioGaia plans direct distribution in Canada; and private-equity firm Ardian takes a stake in French e-commerce supplements specialist Nutripure.

BioGaia Benefits From Easing COVID Restrictions And US Launches

Swedish probiotics player BioGaia reported a big rise in sales in Q1 thanks to the end of pandemic restrictions in Europe and the growth of its operations in the US.

UK Proposes Accelerating Authorizations Of Novel Supplements Like CBD

UK Food Standards Agency proposes shaving a minimum of three months off novel food authorization procedure as part of wider plans to shake-up the process for products like CBD supplements.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152096

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel